A bill to provide for approval of certain drugs and biological products indicated for use in a limited population of patients in order to address increases in bacterial and fungal resistance to drugs and biological products, and for other purposes; to the Committee on Energy and Commerce.

H.R. 3742 — A bill to provide for approval of certain drugs and biological products indicated for use in a limited population of patients in order to address increases in bacterial and fungal resistance to drugs and biological products, and for other purposes; to the Committee on Energy and Commerce.

Cosponsors added, H2611 [24MR], H3242 [28AP], H4017 [8MY], H4910 [28MY], H6036 [9JY], H6107 [10JY], H6297 [15JY], H6400 [17JY], H6656 [22JY], H7041 [29JY], H7128 [30JY], H7297 [8SE], H7389 [9SE], H7455 [11SE], H7529 [15SE], H7619 [16SE], H7939 [12NO], H8133 [19NO], H8171 [20NO]